EGCG treatment of human oral squamous cell carcinoma cell lines partially reversed the hypermethylation status of the RECK gene, a matrix metalloproteinase inhibitor, and increased RECK expression, consequently, extracellular matrix degradation was inhibited and cell invasion was suppressed (92). The gene discussed is RECK; the disease is oral cavity squamous cell carcinoma.